Interpace Diagnostic
IDXG
Delayed Nasdaq - 11/17 08:30:53 pm
1.21USD
0%
Upcoming events
03/07/18
FY 2017 Earnings Release (Projected)
05/14/18
Q1 2018 Earnings Release (Projected)
08/15/18
Interim 2018 Earnings Release (Projected)
Past Events
11/13/17 | 02:30pmQ3 2017 Earnings Call
11/13/17Q3 2017 Earnings Release
10/19/17 | 05:30pmDawson James Securities Small Cap Growth Conference
09/11/17 | 10:40pmRodman & Renshaw Global Investment Conference
Annual results
Annual results20142017 (e)
Sales
Million $
Released
Forecast
Spread
120
123
-2,2%

15,8
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-6,10
-11,5
47%


Operating profit (EBIT)
Million $
Released
Forecast
Spread
-10,6
-14,2
25%

-5,46
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread




Net income
Million $
Released
Forecast
Spread
-16,1
-16,0
-0,54%

-9,63
EPS
 $
Released
Forecast
Spread
-10,8
-10,8
0,00%

-0,47
Announcement Date03/03/2015
Quarterly / Semiannualy publications
Quarterly resultsQ3
2017
Q4
2017 (e)
Sales
Million $
Released
Forecast
Spread
4,20
4,05
3,8%

4,30
Operating income (EBITDA)
 
Released
Forecast
Spread




Operating profit (EBIT)
Million $
Released
Forecast
Spread
-2,28
-2,48
7,8%

-2,47
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread




Net income
Million $
Released
Forecast
Spread
-3,32
-2,48
-34%

-2,42
EPS
 $
Released
Forecast
Spread
-0,15
-0,26
42%

-0,09
Announcement Date11/13/2017
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise